588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Personalized Neoantigen Tumor Vaccine Acute Myeloid Leukemia	Shanghai Jiao Tong University School of Medicine	Early P1	C (33)
Samalizumab Acute Myeloid Leukemia	Beat AML, LLC	P1/2	C (33)
Entospletinib Acute Myeloid Leukemia	Gilead Sciences	P1/2	D (31)
Tagraxofusp-Erzs Acute Myeloid Leukemia	City of Hope Medical Center	P1/2	D (31)
Allogeneic Γδ T Cells Acute Myeloid Leukemia	Donghua Zhang	N/A	D (30)
Car--Γδt Cells Acute Myeloid Leukemia	Hebei Senlang Biotechnology Inc., Ltd.	N/A	D (30)
Donor T Cells Acute Myeloid Leukemia	Dana-Farber Cancer Institute	P1	D (30)
Lilrb4 Star-T Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (30)
Mtz Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (30)
NKG2D CAR-NK Acute Myeloid Leukemia	Zhejiang University	N/A	D (30)
Tomivosertib Acute Myeloid Leukemia	Northwestern University	P1	D (29)
Adrenomedullin Acute Myeloid Leukemia	Gruppo Italiano Malattie EMatologiche dell'Adulto	N/A	D (26)
Alloreactive Nk Cell Infusion Acute Myeloid Leukemia	IRCCS Azienda Ospedaliero-Universitaria di Bologna	N/A	D (26)
Luveltamab Tazevibulin Acute Myeloid Leukemia	Sutro Biopharma, Inc.	P1/2	D (26)
ft538 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P1	D (25)
Autologous Hla-A*02:01-Restricted Cd4+ T-Cells Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	NR ()
bal0891 Acute Myeloid Leukemia	SillaJen, Inc.	P1	NR ()
Byon4413 Acute Myeloid Leukemia	Byondis B.V.	P1	NR ()
Car-Itnk Cells Targeting Cd70 And Cll1 Acute Myeloid Leukemia	Tongji Hospital	Early P1	NR ()
Cctx-001 Acute Myeloid Leukemia	Advesya SAS	P1/2	NR ()
cd84-cart Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	Early P1	NR ()
Cll-1 And Cd123 Dual-Target Car-T Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	Early P1	NR ()
ct0991 car-t cells infusicn Acute Myeloid Leukemia	MEI HENG	P1	NR ()
GT737 Acute Myeloid Leukemia	Grit Biotechnology	Early P1	NR ()
Hpb-092 Acute Myeloid Leukemia	Hangzhou Polymed Biopharmaceuticals, Inc.	P1	NR ()
il3 car t-cells Acute Myeloid Leukemia	Zhejiang University	Early P1	NR ()
IPN60340 Acute Myeloid Leukemia	Ipsen	P2/3	NR ()
ncr300 Acute Myeloid Leukemia	Nuwacell Biotechnologies Co., Ltd.	P1	NR ()
Nei-01 Acute Myeloid Leukemia	New Epsilon Innovation Limited	P1	NR ()
Plm-102 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	NR ()
Rd-Iit-001 Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	Early P1	NR ()
s227928 Acute Myeloid Leukemia	Servier Bio-Innovation LLC	P1/2	NR ()
wbc100 qd Acute Myeloid Leukemia	Hangzhou Weben Pharma Co., Ltd	P1	NR ()

Showing 551 to 588 of 588 assets

PreviousPage 12 of 12Next